2615 Decision-analytic modelling of strategies for investigating suspected acute aortic syndrome

<h3>Aims and Objectives</h3> Acute aortic syndrome (AAS) requires urgent diagnosis with computer tomographic angiography (CTA). Diagnostic strategies using clinical scores and blood tests can select patients for CTA. Identifying an appropriate strategy involves weighing the benefits of detecting AAS against the harms and costs of over-investigation. We aimed to estimate the cost-effectiveness of diagnostic strategies using the Aortic Dissection Detection Risk Score (ADD-RS) and/or D-dimer to select patients with potential symptoms of AAS for CTA. <h3>Method and Design</h3> We developed a decision-analytic model to simulate the management of patients attending hospital with possible AAS. We modelled diagnostic strategies that used the ADD-RS and/or D-dimer to select patients for CTA. We used estimates from our meta-analysis, existing literature, and clinical experts to model the consequences of diagnostic strategies upon survival, health utility, and health and social care costs. We estimated the incremental cost per quality-adjusted life years (QALYs) gained by each strategy compared to the next most effective alternative on the efficiency frontier. <h3>Results and Conclusion</h3> A strategy based on the Canadian guideline (CTA if ADD-RS&gt;1 or ADD-RS=1 with D-dimer&gt;500ng/mL) is cost-effective but would result in high rates of CTA if applied to an unselected population (AAS prevalence 0.26%). The strategy is also cost-effective and would result in lower rates of CTA if applied to a more selected population, such as those with a non-zero clinical suspicion of AAS (prevalence 0.61%). For patients currently receiving CTA, using ADD RS&gt;1 or D-Dimer&gt;500ng/mL to select patients for CTA is cost-effective. A strategy using ADD RS&gt;1 or ADD RS=1 with D-dimer&gt;500ng/mL to select patients for CTA appears cost-effective but primary research is required to evaluate this strategy in practice and determine how suspicion of AAS is identified.

Authors

Institutions

Publication Details

Published
2024-09-30
DOI
https://doi.org/10.1136/emermed-2024-rcem.20
Primary Topic
Hemodynamic Monitoring and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

2615 Decision-analytic modelling of strategies for investigating suspected acute aortic syndrome

Catherine Fowler, Robert J. Hinchliffe, Steve Goodacre, Praveen Thokala et al.
Hemodynamic Monitoring and Therapy
article

2615 Decision-analytic modelling of strategies for investigating suspected acute aortic syndrome

Catherine Fowler, Robert J. Hinchliffe, Steve Goodacre, Praveen Thokala, Matthew J. Reed, Sarah Wilson, Graham Cooper, Steven Thomas, Valérie Lechene
article en

Abstract

<h3>Aims and Objectives</h3> Acute aortic syndrome (AAS) requires urgent diagnosis with computer tomographic angiography (CTA). Diagnostic strategies using clinical scores and blood tests can select patients for CTA. Identifying an appropriate strategy involves weighing the benefits of detecting AAS against the harms and costs of over-investigation. We aimed to estimate the cost-effectiveness of diagnostic strategies using the Aortic Dissection Detection Risk Score (ADD-RS) and/or D-dimer to select patients with potential symptoms of AAS for CTA. <h3>Method and Design</h3> We developed a decision-analytic model to simulate the management of patients attending hospital with possible AAS. We modelled diagnostic strategies that used the ADD-RS and/or D-dimer to select patients for CTA. We used estimates from our meta-analysis, existing literature, and clinical experts to model the consequences of diagnostic strategies upon survival, health utility, and health and social care costs. We estimated the incremental cost per quality-adjusted life years (QALYs) gained by each strategy compared to the next most effective alternative on the efficiency frontier. <h3>Results and Conclusion</h3> A strategy based on the Canadian guideline (CTA if ADD-RS&gt;1 or ADD-RS=1 with D-dimer&gt;500ng/mL) is cost-effective but would result in high rates of CTA if applied to an unselected population (AAS prevalence 0.26%). The strategy is also cost-effective and would result in lower rates of CTA if applied to a more selected population, such as those with a non-zero clinical suspicion of AAS (prevalence 0.61%). For patients currently receiving CTA, using ADD RS&gt;1 or D-Dimer&gt;500ng/mL to select patients for CTA is cost-effective. A strategy using ADD RS&gt;1 or ADD RS=1 with D-dimer&gt;500ng/mL to select patients for CTA appears cost-effective but primary research is required to evaluate this strategy in practice and determine how suspicion of AAS is identified.

Edinburgh Royal Infirmary (GB), Frimley Health NHS Foundation Trust (GB), University of Bristol (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), University of Sheffield (GB)
Peace, Justice and strong institutions
Openalex Percentile: Top 69%
Hemodynamic Monitoring and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.